vs
Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and STONERIDGE INC (SRI). Click either name above to swap in a different company.
STONERIDGE INC is the larger business by last-quarter revenue ($205.2M vs $148.5M, roughly 1.4× OPKO HEALTH, INC.). On growth, STONERIDGE INC posted the faster year-over-year revenue change (-6.0% vs -19.2%). STONERIDGE INC produced more free cash flow last quarter ($2.6M vs $-28.6M). Over the past eight quarters, STONERIDGE INC's revenue compounded faster (-7.4% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
OPK vs SRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.5M | $205.2M |
| Net Profit | $-31.3M | — |
| Gross Margin | 43.1% | 16.2% |
| Operating Margin | -25.8% | -14.4% |
| Net Margin | -21.1% | — |
| Revenue YoY | -19.2% | -6.0% |
| Net Profit YoY | -322.8% | — |
| EPS (diluted) | $-0.04 | $-2.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.5M | $205.2M | ||
| Q3 25 | $151.7M | $210.3M | ||
| Q2 25 | $156.8M | $228.0M | ||
| Q1 25 | $150.0M | $217.9M | ||
| Q4 24 | $183.6M | $218.2M | ||
| Q3 24 | $173.6M | $213.8M | ||
| Q2 24 | $182.2M | $237.1M | ||
| Q1 24 | $173.7M | $239.2M |
| Q4 25 | $-31.3M | — | ||
| Q3 25 | $21.6M | $-9.4M | ||
| Q2 25 | $-148.4M | $-9.4M | ||
| Q1 25 | $-67.6M | $-7.2M | ||
| Q4 24 | $14.0M | — | ||
| Q3 24 | $24.9M | $-7.1M | ||
| Q2 24 | $-10.3M | $2.8M | ||
| Q1 24 | $-81.8M | $-6.1M |
| Q4 25 | 43.1% | 16.2% | ||
| Q3 25 | 32.9% | 20.3% | ||
| Q2 25 | 31.5% | 21.5% | ||
| Q1 25 | 28.4% | 21.2% | ||
| Q4 24 | 46.1% | 19.5% | ||
| Q3 24 | 23.1% | 20.8% | ||
| Q2 24 | 28.4% | 22.7% | ||
| Q1 24 | 24.2% | 20.2% |
| Q4 25 | -25.8% | -14.4% | ||
| Q3 25 | 31.7% | -1.6% | ||
| Q2 25 | -38.3% | -1.1% | ||
| Q1 25 | -44.8% | -1.5% | ||
| Q4 24 | -18.0% | -2.0% | ||
| Q3 24 | 8.2% | 0.1% | ||
| Q2 24 | -33.9% | 1.4% | ||
| Q1 24 | -41.2% | 0.1% |
| Q4 25 | -21.1% | — | ||
| Q3 25 | 14.3% | -4.5% | ||
| Q2 25 | -94.7% | -4.1% | ||
| Q1 25 | -45.1% | -3.3% | ||
| Q4 24 | 7.6% | — | ||
| Q3 24 | 14.3% | -3.3% | ||
| Q2 24 | -5.7% | 1.2% | ||
| Q1 24 | -47.1% | -2.6% |
| Q4 25 | $-0.04 | $-2.76 | ||
| Q3 25 | $0.03 | $-0.34 | ||
| Q2 25 | $-0.19 | $-0.34 | ||
| Q1 25 | $-0.10 | $-0.26 | ||
| Q4 24 | $0.02 | $-0.22 | ||
| Q3 24 | $0.03 | $-0.26 | ||
| Q2 24 | $-0.01 | $0.10 | ||
| Q1 24 | $-0.12 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $364.4M | $66.3M |
| Total DebtLower is stronger | $344.0M | $180.9M |
| Stockholders' EquityBook value | $1.3B | $179.8M |
| Total Assets | $1.9B | $551.2M |
| Debt / EquityLower = less leverage | 0.27× | 1.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $364.4M | $66.3M | ||
| Q3 25 | $412.0M | $54.0M | ||
| Q2 25 | $267.3M | $49.8M | ||
| Q1 25 | $428.8M | $79.1M | ||
| Q4 24 | $426.6M | $71.8M | ||
| Q3 24 | $400.1M | $54.1M | ||
| Q2 24 | $40.6M | $42.1M | ||
| Q1 24 | $75.6M | $48.4M |
| Q4 25 | $344.0M | $180.9M | ||
| Q3 25 | $344.2M | — | ||
| Q2 25 | $343.3M | — | ||
| Q1 25 | $439.2M | — | ||
| Q4 24 | $437.2M | $201.6M | ||
| Q3 24 | $441.0M | — | ||
| Q2 24 | $201.9M | — | ||
| Q1 24 | $350.1M | — |
| Q4 25 | $1.3B | $179.8M | ||
| Q3 25 | $1.3B | $251.2M | ||
| Q2 25 | $1.3B | $260.5M | ||
| Q1 25 | $1.3B | $253.1M | ||
| Q4 24 | $1.4B | $245.3M | ||
| Q3 24 | $1.4B | $271.4M | ||
| Q2 24 | $1.4B | $270.5M | ||
| Q1 24 | $1.3B | $277.3M |
| Q4 25 | $1.9B | $551.2M | ||
| Q3 25 | $2.0B | $632.1M | ||
| Q2 25 | $2.0B | $639.4M | ||
| Q1 25 | $2.1B | $657.4M | ||
| Q4 24 | $2.2B | $621.6M | ||
| Q3 24 | $2.3B | $662.5M | ||
| Q2 24 | $2.0B | $666.7M | ||
| Q1 24 | $2.0B | $675.4M |
| Q4 25 | 0.27× | 1.01× | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.32× | 0.82× | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.9M | $8.8M |
| Free Cash FlowOCF − Capex | $-28.6M | $2.6M |
| FCF MarginFCF / Revenue | -19.3% | 1.3% |
| Capex IntensityCapex / Revenue | 1.8% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-190.8M | $12.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.9M | $8.8M | ||
| Q3 25 | $-34.6M | $3.6M | ||
| Q2 25 | $-83.4M | $10.7M | ||
| Q1 25 | $-34.6M | $10.9M | ||
| Q4 24 | $-44.4M | $19.2M | ||
| Q3 24 | $-77.1M | $10.8M | ||
| Q2 24 | $-26.4M | $8.7M | ||
| Q1 24 | $-35.6M | $9.1M |
| Q4 25 | $-28.6M | $2.6M | ||
| Q3 25 | $-37.8M | $-2.7M | ||
| Q2 25 | $-86.7M | $7.4M | ||
| Q1 25 | $-37.7M | $4.8M | ||
| Q4 24 | $-49.8M | $14.0M | ||
| Q3 24 | $-85.0M | $4.6M | ||
| Q2 24 | $-33.7M | $1.5M | ||
| Q1 24 | $-40.0M | $3.3M |
| Q4 25 | -19.3% | 1.3% | ||
| Q3 25 | -24.9% | -1.3% | ||
| Q2 25 | -55.3% | 3.3% | ||
| Q1 25 | -25.2% | 2.2% | ||
| Q4 24 | -27.1% | 6.4% | ||
| Q3 24 | -49.0% | 2.2% | ||
| Q2 24 | -18.5% | 0.6% | ||
| Q1 24 | -23.0% | 1.4% |
| Q4 25 | 1.8% | 3.0% | ||
| Q3 25 | 2.1% | 3.0% | ||
| Q2 25 | 2.1% | 1.4% | ||
| Q1 25 | 2.1% | 2.8% | ||
| Q4 24 | 2.9% | 2.4% | ||
| Q3 24 | 4.6% | 2.9% | ||
| Q2 24 | 4.0% | 3.0% | ||
| Q1 24 | 2.6% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | -1.60× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.17× | — | ||
| Q3 24 | -3.10× | — | ||
| Q2 24 | — | 3.11× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
